Literature DB >> 15133329

Uric acid, phosphate and oxalate stones: treatment and prophylaxis.

G Caramia1, L Di Gregorio, M L Tarantino, A Galuffo, R Iacolino, M Caramia.   

Abstract

Medical treatment for the most commonly encountered types of renal stones is described. Nowadays treatment for uric acid stones is well-defined: alkalinizing urine is easy with drugs that are sufficiently active and well enough managed. Relapse is avoided in a high percentage of patients. Medical treatment of phosphate or calcium stones is a more open question as results are far from satisfactory compared with intra- and extra-corporeal approaches which are often minimally invasive and well accepted by both patient and urologist. Relapses are not easy to control because prophylactic measures such as changes in lifestyle and diet are never activated or because they are adopted for a brief period of time. Water therapy is examined, with the choice of water depending on the type of stone, together with drug therapy. Drugs such as citrate, with or without magnesium, and thiazides are considered excellent for curing renal stones and relapses. Although medical therapy has a limited role in many types of stones, its use is decisive in some others. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15133329     DOI: 10.1159/000076587

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  3 in total

1.  The effect of terpene combination on ureter calculus expulsion after extracorporeal shock wave lithotripsy.

Authors:  Dai Hee Kim; Hyeok Jun Goh; Ho Won Lee; Kyu Shik Kim; Yong Tae Kim; Hong Sang Moon; Seung Wook Lee; Sung Yul Park
Journal:  Korean J Urol       Date:  2014-01-15

2.  Renal colic during sexual intercourse: a unique presentation.

Authors:  L Wilson; A B Patel
Journal:  Urol Res       Date:  2006-02-14

3.  The Association of Uric Acid Calculi with Obesity, Prediabetes, Type 2 Diabetes Mellitus, and Hypertension.

Authors:  Fang-Yeh Chu; Chih-Chun Chang; Pin-Hao Huang; Yi-Ning Lin; Po-Wen Ku; Jen-Tang Sun; Jung-Li Ho; Tzung-Hai Yen; Ming-Jang Su
Journal:  Biomed Res Int       Date:  2017-08-23       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.